Rue de Jargonnant 2
1207 Genève
Neighbourhood
Reports for Calypte Biomedical Corporation, Wilmington, Geneva Branch, en liquidation
Credit rating information
Evaluation of credit rating with traffic light as risk indicator and other helpful data about the company.Find out more
Economic information
Comprehensive information about the economic situation of a company.Find out more
Payment collection information
Overview of current and past debt enforcement proceedings.Find out more
Company dossier as PDF
Contact information, changes in the company, turnover and employee figures, management, ownership, shareholding structure and other company data.Retrieve company dossier
About Calypte Biomedical Corporation, Wilmington, Geneva Branch, en liquidation
- Calypte Biomedical Corporation, Wilmington, Geneva Branch, en liquidation is active in the industry «Religious, political or secular associations» and is currently in liquidation. The legal headquarters are in Genève.
- The management of the company Calypte Biomedical Corporation, Wilmington, Geneva Branch, en liquidation consists of 7 persons.
- The last commercial register change was made on 18.08.2025. All changes can be viewed under the section «Notifications» and saved as a PDF.
- The reported UID is the following: CHE-113.891.527.
- Companies with an identical address: 53 House SA, Advanz Pharma Switzerland Sàrl, Altiore Consulting Sàrl.
Management (7)
Director of branch office
Jerrold D. Dotson,
Adel Karas,
John J. DiPietro,
Julius R. Krevans,
Maxim Andreevich Soulimov
newest authorized signatories
Commercial register information
Entry in the commercial register
24.10.2007
Legal form
Branch with head office abroad
Legal headquarters of the company
Genève
Commercial Registry Office
GE
Commercial register number
CH-660.2.088.007-2
UID/VAT
CHE-113.891.527
Sector
Religious, political or secular associations
Purpose (Original language)
Représenter les intérêts de Calypte Biomedical Corporation au niveau international. Calypte Biomedical Corporation est une compagnie fournissant des prestations dans le domaine de la santé. Elle est spécialisée dans le développement et la commercialisation de produits permettant d'effectuer des tests rapides pour détecter le virus d'immunodéficience humain, les maladies sexuellement transmissibles et autres maladies chroniques.
Other company names
Past and translated company names
- Calypte Biomedical Corporation, Wilmington, Geneva Branch
Other branches (0)
Ownership structure
Holdings
Newest SOGC notifications: Calypte Biomedical Corporation, Wilmington, Geneva Branch, en liquidation
The latest updates from the Swiss Official Gazette of Commerce (SOGC) are available in the original language of the source commercial register office only. View all notifications
Publication number: KK01-0000052479, Commercial Registry Office Geneva
Rubrique: Faillites Sous-rubrique: Avis préalable d'ouverture de faillite Date de publication: SHAB 18.08.2025 Publications supplémentaires: KABGE 18.08.2025 Visible par le public jusqu¿au: 18.08.2030 Numéro de publication: Entité de publication Office des faillites de l'Etat Genève, Route de Chêne 54, 1211 Genève 6 Avis préalable d'ouverture de faillite CALYPTE BIOMEDICAL CORPORATION, WILMINGTON, GENEVA BRANCH, EN LIQUIDATION Débiteurs: CALYPTE BIOMEDICAL CORPORATION, WILMINGTON, GENEVA BRANCH, EN LIQUIDATION CHE-113.891.527 rue de Jargonnant 2
domaine de la santé. Elle est spécialisée dans le développement et la commercialisation de produits permettant d'effectuer des tests rapides pour détecter le virus d'immunodéficience humain, les maladies sexuellement transmissibles et autres
maladies chroniques.
Publication number: HR02-1006381396, Commercial Registry Office Geneva, (660)
Calypte Biomedical Corporation, Wilmington, Geneva Branch, à Genève, CHE-113.891.527 (FOSC du 22.04.2024, p. 0/1006014952). Par décision du juge du Tribunal de première instance du 12.06.2025, la succursale a été dissoute conformément à l'art. 731b CO;
sa liquidation a été ordonnée selon les dispositions applicables à la faillite.
Sa liquidation est opérée sous la raison de commerce:
Calypte Biomedical Corporation, Wilmington, Geneva Branch, en liquidation.
Publication number: HR02-1006014952, Commercial Registry Office Geneva, (660)
Calypte Biomedical Corporation, Wilmington, Geneva Branch, à Genève, CHE-113.891.527 (FOSC du 19.12.2013, p. 0/7225832). Les pouvoirs de Janjalia Khatuna sont radiés.
Hit list
Here you will find a link from the management to a hit list of persons with the same name who are registered in the commercial register.